- Report
- August 2023
- 133 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2642EUR$2,750USD£2,259GBP
- Report
- October 2023
- 177 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Report
- March 2024
- 397 Pages
Global
From €7639EUR$7,950USD£6,531GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,232GBP
- Report
- October 2023
- 145 Pages
Global
From €3027EUR$3,150USD£2,588GBP
- Report
- February 2021
- 420 Pages
United States
From €2306EUR$2,400USD£1,972GBP
- Report
- November 2023
- 92 Pages
China
From €1730EUR$1,800USD£1,479GBP
- Report
- June 2020
- 113 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2642EUR$2,750USD£2,259GBP
- Report
- October 2022
- 113 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- March 2021
- 101 Pages
Global
€21139EUR$22,000USD£18,072GBP
- Report
- July 2019
- 498 Pages
Global
€21139EUR$22,000USD£18,072GBP
- Report
- March 2019
- 62 Pages
Global
€9608EUR$10,000USD£8,215GBP
- Report
- March 2019
- 33 Pages
Global
€9608EUR$10,000USD£8,215GBP
- Report
- March 2018
- 16 Pages
Global
From €9608EUR$10,000USD£8,215GBP
- Report
- November 2023
- 251 Pages
China
From €3843EUR$4,000USD£3,286GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- January 2024
- 83 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$3,902USD£3,097GBP
Aripiprazole is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a dopamine partial agonist, meaning it works by stimulating dopamine receptors in the brain. Aripiprazole is also used to treat irritability and symptoms associated with autism spectrum disorder. It is available in both oral and injectable forms.
Aripiprazole is generally well-tolerated and has fewer side effects than other antipsychotic medications. It is also less likely to cause weight gain and metabolic changes than other antipsychotics.
The aripiprazole market is highly competitive, with many companies offering generic versions of the drug. Companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals are some of the major players in the market. Other companies such as Dr. Reddy's Laboratories, Lupin, and Torrent Pharmaceuticals also offer generic versions of the drug. Show Less Read more